Skip to main navigation Skip to search Skip to main content

Novel Recombinant BCG for Immunotherapy of Bladder Cancer

Project: Research

Project Details

StatusFinished
Effective start/end date10/27/20 → 10/26/21

Funding

  • Manhattan BioSolutions Incorporated: $10,000.00